These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17653094)

  • 1. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
    Bae SI; Cheriyath V; Jacobs BS; Reu FJ; Borden EC
    Oncogene; 2008 Jan; 27(4):490-8. PubMed ID: 17653094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
    J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
    Reu FJ; Leaman DW; Maitra RR; Bae SI; Cherkassky L; Fox MW; Rempinski DR; Beaulieu N; MacLeod AR; Borden EC
    Cancer Res; 2006 Mar; 66(5):2785-93. PubMed ID: 16510600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas.
    Elias A; Siegelin MD; Steinmüller A; von Deimling A; Lass U; Korn B; Mueller W
    Clin Cancer Res; 2009 Sep; 15(17):5457-65. PubMed ID: 19706813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
    Horak P; Pils D; Haller G; Pribill I; Roessler M; Tomek S; Horvat R; Zeillinger R; Zielinski C; Krainer M
    Mol Cancer Res; 2005 Jun; 3(6):335-43. PubMed ID: 15972852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.
    Chawla-Sarkar M; Leaman DW; Borden EC
    Clin Cancer Res; 2001 Jun; 7(6):1821-31. PubMed ID: 11410525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of TRAIL/Apo2L-induced apoptosis by low-dose interferon-β in human malignant melanoma cells.
    Kazaana A; Sano E; Yoshimura S; Makita K; Hara H; Yoshino A; Ueda T
    J Cell Physiol; 2019 Aug; 234(8):13510-13524. PubMed ID: 30613977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of TRAIL resistance by radiation-induced hypermethylation of DR4 CpG island in recurrent laryngeal squamous cell carcinoma.
    Lee JC; Lee WH; Min YJ; Cha HJ; Han MW; Chang HW; Kim SA; Choi SH; Kim SW; Kim SY
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1203-11. PubMed ID: 24661673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of DR4 promoter methylation on the TRAIL-induced apoptosis in lung squamous carcinoma cell.
    Wang W; Qi X; Wu M
    Oncol Rep; 2015 Oct; 34(4):2115-25. PubMed ID: 26238205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma.
    Borden EC
    Cytokine Growth Factor Rev; 2007; 18(5-6):491-501. PubMed ID: 17689283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis.
    Akahane K; Inukai T; Zhang X; Hirose K; Kuroda I; Goi K; Honna H; Kagami K; Nakazawa S; Endo K; Kubota T; Yagita H; Koyama-Okazaki T; Sugita K
    Exp Hematol; 2010 Oct; 38(10):885-95. PubMed ID: 20670671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of the XAF1 gene by promoter hypermethylation in cancer cells and reactivation to TRAIL-sensitization by IFN-beta.
    Micali OC; Cheung HH; Plenchette S; Hurley SL; Liston P; LaCasse EC; Korneluk RG
    BMC Cancer; 2007 Mar; 7():52. PubMed ID: 17376236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
    Grotzer MA; Eggert A; Zuzak TJ; Janss AJ; Marwaha S; Wiewrodt BR; Ikegaki N; Brodeur GM; Phillips PC
    Oncogene; 2000 Sep; 19(40):4604-10. PubMed ID: 11030149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S; Frese-Schaper M; Andres AC; Miescher D; Zumkehr B; Schmid RA
    Cancer Res; 2006 Jun; 66(11):5867-74. PubMed ID: 16740726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased caspase-2 activity is associated with induction of apoptosis in IFN-beta sensitive melanoma cell lines.
    Kamiya T; Okabayashi T; Yokota S; Kan Y; Ogino J; Yamashita T; Fujii N; Jimbow K
    J Interferon Cytokine Res; 2010 May; 30(5):349-57. PubMed ID: 20187765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L/TRAIL.
    Gómez-Benito M; Martinez-Lorenzo MJ; Anel A; Marzo I; Naval J
    Exp Cell Res; 2007 Jul; 313(11):2378-88. PubMed ID: 17462628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
    Gomi K; Akinaga S; Oka T; Morimoto M
    Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
    Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
    Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis.
    Chawla-Sarkar M; Leaman DW; Jacobs BS; Borden EC
    J Immunol; 2002 Jul; 169(2):847-55. PubMed ID: 12097388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.